[go: up one dir, main page]

Spiller et al., 1984 - Google Patents

Treatment of basal cell epithelioma by curettage and electrodesiccation

Spiller et al., 1984

Document ID
766334507671076768
Author
Spiller W
Spiller R
Publication year
Publication venue
Journal of the American Academy of Dermatology

External Links

Snippet

A total of 233 biopsy-proved basal cell epitheliomas (BCEs) treated by curettage and electrodesiccation (C&D) in our office in 1976 and 1977 were followed a minimum of 5 years. There were seven recurrences, a cure rate of 97.0%. Our results, both for recurrence …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
    • A61K8/19—Cosmetic or similar toilet preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
    • A61K8/30—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/54—Chiropodists' instruments, e.g. pedicure

Similar Documents

Publication Publication Date Title
Spiller et al. Treatment of basal cell epithelioma by curettage and electrodesiccation
Salasche Curettage and electrodesiccation in the treatment of midfacial basal cell epithelioma
d'Aubermont et al. Failure of curettage and electrodesiccation for removal of basal cell carcinoma
Koplin et al. Recurrent basal cell carcinoma: a review concerning the incidence, behavior, and management of recurrent basal cell carcinoma, with emphasis on the incompletely excised lesion
Williamson et al. Treatment of basal cell carcinoma by electrodesiccation and curettage
Honeycutt et al. Treatment of squamous cell carcinoma of the skin
Crissey Curettage and electrodesiccation as a method of treatment for epitheliomas of the skin
Mohs et al. Microscopically controlled surgery in the treatment of carcinoma of the scalp
Reymann Basal cell carcinoma of the skin recurrence rate after different types of treatment: a review
Levine et al. Tissue conservation in treatment of cutaneous neoplasms of the head and neck: combined use of Mohs' chemosurgical and conventional surgical techniques
Freeman et al. Treatment of skin cancer
COSTELLO et al. Melanotic freckle: Lentigo maligna
SHELLEY et al. Occult Bowen's disease in keratinous cysts
Barton Jr et al. The principle of chemosurgery and delayed primary reconstruction in the management of difficult basal cell carcinomas
Jackson Why do basal cell carcinomas recur (or not recur) following treatment?
FERRARA The private dermatologist and skin cancer: a clinical study of two hundred twenty-six epitheliomas derived from five dermatologic practices
Vargo Basal cell and squamous cell carcinoma
Reymann Treatment of keratoacanthomas with curettage
SPERBER Chemexfoliation for aging skin and acne scarring
Swanson et al. Management of basal and squamous cell carcinoma
Piest Malignant lesions of the eyelids
Belisario Modern treatment of skin cancer.
Popkin et al. Excision versus curettage and electrodesiccation as dermatologic office procedures for the treatment of basal-cell carcinomas
Pickrell et al. Tumors of the head and neck in infancy, childhood, and adolescence
Goldschmidt et al. Radiation therapy of cutaneous carcinomas: radiation techniques and dose schedules